Log in to save to my catalogue

Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular...

Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5520920

Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption

About this item

Full title

Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2017-06, Vol.8 (6), p.e2875-e2875

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

BRCA2
encodes a protein with a fundamental role in homologous recombination that is essential for normal development. Carrier status of mutations
in BRCA2
is associated with familial breast and ovarian cancer, while bi-allelic
BRCA2
mutations can cause Fanconi anemia (FA), a cancer predisposition syndrome with cellular cross-linker h...

Alternative Titles

Full title

Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5520920

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5520920

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/cddis.2017.264

How to access this item